vyrarx review

vyrarx for mothers: our verdict

Publishes a floor and calls it a price — read live on August 21, 2026 the site says "From $179 /mo" for semaglutide and "From $329 /mo" for tirzepatide, and the word from is doing real work in both. No dose ladder, no maintenance rate and no ceiling appear anywhere on the public site, which means the number you would actually pay once you titrate up is the one piece of information the page does not give you. That matters more here than on a flat-price seller, because a floor tells you only where the billing starts. On the disclosure side it does better than several listings here: it names its operating entity, vyrarx, Inc., in its own Terms, and it has no FDA warning letter. No state list is published, and nothing on the site addresses pregnancy, breastfeeding or postpartum timing. It runs about $179/month.

We weigh vyrarx the way mothers actually have to: not just the monthly cost, but postpartum and breastfeeding timing and PCOS and insulin resistance — the parts a general weight-loss roundup leaves out.

What vyrarx costs, in full

• Compounded semaglutide — Injection: $179/mo
• Compounded tirzepatide — Injection: $329/mo

That lands within a few dollars of the ~$179/month median across the providers we track, so the monthly cost isn't what should decide this one either way. Weigh it instead on postpartum and breastfeeding timing and PCOS and insulin resistance, and on what the price actually includes — a lower number that leaves out labs, visits or shipping is not the cheaper option.

On that last point vyrarx is no help: it doesn't break down what the monthly figure covers — whether the provider visit, shipping and any lab work are inside it or billed separately. Ask before you pay, because that answer is what decides whether a mid-range price is actually mid-range.

The medications vyrarx prescribes

vyrarx prescribes semaglutide and tirzepatide — the two with the largest published weight-loss effects, and carrying both on one account matters when insulin resistance, common with PCOS and after gestational diabetes, makes tirzepatide the better-suited option. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.

Where vyrarx fits — and where it doesn't — for mothers

A good fit if…

• the monthly cost is a real barrier and you want a low, predictable number.
• switching between semaglutide and tirzepatide may become necessary as your body and your hormones change.

Look elsewhere if…

• you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
• you'd rather a prescriber talk through timing around postpartum and breastfeeding timing — that is the ground our #1 pick, CoreAge Rx, is built on.

Oversight, safety, and what we could verify

Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.

A standing caveat for mothers: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.

The bottom line

vyrarx is a reasonable option — weigh it on postpartum and breastfeeding timing and PCOS and insulin resistance against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.